The conversation highlights a troubling dynamic where pharmaceutical companies prioritize profit over safety, leaving public health authorities conflicted and compromised. With no financial incentives to challenge vaccine safety, the lack of accountability creates cognitive dissonance among the public. This raises critical questions about trust in health authorities and the implications for vaccine perceptions.
